ArticleInternational journal of cancer2026

Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study).

Thorsten O Goetze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.